SFO
TMO icon

Stokes Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Stokes Family Office’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$387K Sell
788
-275
-26% -$149K 0.04% 209
2025
Q4 		$616K Buy
1,063
+315
+42% +$178K 0.06% 175
2025
Q3 		$363K Buy
748
+22
+3% +$10.2K 0.03% 209
2025
Q2 		$294K Sell
726
-21
-3% -$8.78K 0.03% 201
2025
Q1 		$372K Sell
747
-42
-5% -$22.7K 0.04% 182
2024
Q4 		$410K Buy
+789
New +$434K 0.04% 177
2023
Q4 		– Sell
-1,196
Closed -$605K – 333
2023
Q3 		$605K Buy
1,196
+56
+5% +$29.8K 0.07% 168
2023
Q2 		$595K Sell
1,140
-52
-4% -$28.1K 0.07% 159
2023
Q1 		$687K Buy
1,192
+171
+17% +$96.4K 0.09% 141
2022
Q4 		$562K Sell
1,021
-255
-20% -$135K 0.07% 150
2022
Q3 		$647K Buy
1,276
+178
+16% +$99.6K 0.09% 134
2022
Q2 		$597K Buy
1,098
+65
+6% +$35.8K 0.08% 147
2022
Q1 		$610K Sell
1,033
-119
-10% -$68.4K 0.08% 148
2021
Q4 		$769K Buy
1,152
+21
+2% +$13.1K 0.1% 122
2021
Q3 		$646K Buy
1,131
+21
+2% +$11.5K 0.09% 127
2021
Q2 		$560K Buy
1,110
+53
+5% +$25K 0.08% 131
2021
Q1 		$505K Buy
1,057
+90
+9% +$43K 0.08% 130
2020
Q4 		$450K Buy
+967
New +$453K 0.09% 116

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stokes Family Office's TMO Position: Q1 2026 in Review

Stokes Family Office reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q1 2026, selling an estimated $149K and leaving 788 shares worth $387K. The position accounts for 0.04% of the portfolio, ranked #209.

Stokes Family Office first reported a position in TMO in Q4 2020 and has held it in 18 quarters since. The position peaked at $769K in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Stokes Family Office held 788 shares of Thermo Fisher Scientific worth $387K as of Q1 2026.
  • Stokes Family Office sold 275 Thermo Fisher Scientific shares in Q1 2026, an estimated $149K.
  • Thermo Fisher Scientific made up 0.04% of Stokes Family Office's portfolio in Q1 2026, its #209 holding.
  • Stokes Family Office first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 18 quarters since.
  • Stokes Family Office's Thermo Fisher Scientific position peaked at $769K in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.